Initial testing was performed by rapid devices approved by World Health Organization (WHO) and confirmed by Chemiluminescence Immunoassays
Evaluation of two automated chemiluminescence immunoassays
, the LIA-ISON Treponema Screen and the ARCHITECT Syphilis TP, and the Treponema pallidum particle agglutination test for laboratory diagnosis of syphilis.
Abbreviations: RPR = rapid plasma reagin, TPHA = Treponema pallidum hemagglutination, CIA = chemiluminescence immunoassay
, FTA-ABS = fluorescent treponemal antibody-absorption, EIA = enzyme immunoassay, LIA = line immunoassay; ID = indeterminate.
The ADVIA Centaur chemiluminescence immunoassay
assay, which also uses mouse monoclonal anti-CsA antibodies, was not affected by the interference.
Call for exploratory know the market presence of systems (instrumentation kit) similar technical characteristics, instrumental and qualitative semi-automatic system to DSX Technogenetics firm and fully automated system Maglumi Chemiluminescence Immunoassay
Analyzer 600 firm Medical Systems.
is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using enhanced chemiluminescence immunoassay
("ECLIA") technology to detect and monitor various diseases and disorders and high intensity focused ultrasound ("HIFU") tumor therapy systems for the treatment of solid cancers and benign tumors.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets products using high intensity focused ultrasound for the treatment of solid cancers and benign tumors and advanced in-vitro diagnostics products using enhanced chemiluminescence immunoassay
technology, to detect and monitor various diseases and disorders.
Our study was designed to evaluate and compare 3 commercial third-generation assays based on a chemiluminescence immunoassay
, ELISA, and IRMA for bio-intact PTH and to compare these with a second-generation PTH assay.
the "Company") (NASDAQ: CMED), a leading China-based medical device company that develops, manufactures and markets high intensity focused ultrasound products and advanced in-vitro diagnostic systems, today announced that it has successfully completed the development of four liver fibrosis diagnostic reagents that use enhanced chemiluminescence immunoassay
The acridinium conjugates were compared in magnetic chemiluminescence immunoassay
format using magnetic microspheres coated with the same antibody used on the latex microspheres.
We aim to broaden our reagent offering to a total of 70 kits within the next 12 months, which will make us one of the leading providers of chemiluminescence immunoassay
reagents in the industry worldwide"
A new modular chemiluminescence immunoassay